Boehringer Ingelheim and Lilly provide update on Jardiance® phase III exercise ability studies in chronic heart failure - BioSpace Get link Facebook X Pinterest Email Other Apps December 18, 2019 Boehringer Ingelheim and Lilly provide update on Jardiance® phase III exercise ability studies in chronic heart failure BioSpace Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment